Familial hemophagocytic lymphohistiocytosis type 3 presenting as neonatal cholestasis and splenomegaly
- PMID: 35470934
- DOI: 10.1111/pai.13774
Familial hemophagocytic lymphohistiocytosis type 3 presenting as neonatal cholestasis and splenomegaly
Keywords: Munc13-4; UNC13D; cholestasis; familial hemophagocytic lymphohistiocytosis; hemophagocytic lymphohistiocytosis; neonatal.
References
REFERENCES
-
- Canna SW, Marsh RA. Pediatric hemophagocytic lymphohistiocytosis. Blood. 2020;135(16):1332-1343.
-
- Taurisano R, Maiorana A, De Benedetti F, Dionisi-Vici C, Boldrini R, Deodato F. Wolman disease associated with hemophagocytic lymphohistiocytosis: attempts for an explanation. Eur J Pediatr. 2014;173(10):1391-1394.
-
- Ehl S, Astigarraga I, von Bahr Greenwood T, et al. Recommendations for the use of etoposide-based therapy and bone marrow transplantation for the treatment of HLH: consensus statements by the HLH steering committee of the histiocyte society. J Allergy Clin Immunol Pract. 2018;6(5):1508-1517.
-
- Bryceson YT, Pende D, Maul-Pavicic A, et al. A prospective evaluation of degranulation assays in the rapid diagnosis of familial hemophagocytic syndromes. Blood. 2012;119(12):2754-2763.
-
- Amirifar P, Ranjouri MR, Abolhassani H, et al. Clinical, immunological and genetic findings in patients with UNC13D deficiency (FHL3): a systematic review. Pediatr Allergy Immunol. 2021;32(1):186-197.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
